Peptichemio, Vincristine, Prednisone Induction Treatment in Multiple Myeloma
Author:
Affiliation:
1. Istituto di Patologia Medica I, Università di Pavia, Pavia
Publisher
SAGE Publications
Subject
Cancer Research,Oncology,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/030089168507100611
Reference25 articles.
1. Treatment for Multiple Myeloma
2. Combination therapy for multiple myeloma
3. Plasma cell neoplasms
4. Chemotherapy for multiple myeloma
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MODERN APPROACHES IN TREATMENT OF PATIENTS OF MULTIPLE MYELOMES (references review);Health and Ecology Issues;2009-12-28
2. Activity of Hydrolytic Enzymes in Tumour Cells is a Determinant for Anti-tumour Efficacy of the Melphalan Containing ProdrugJ1;Journal of Drug Targeting;2003-07
3. Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cytostatic policy;British Journal of Cancer;1994-12
4. Pharmacokinetics of peptichemio in myeloma patients: release ofm-l-sarcolysin in vivo and in vitro;Cancer Chemotherapy and Pharmacology;1993
5. Peptichemio, vincristine and prednisone versus melphalan and prednisone as induction therapy in multiple myeloma;European Journal of Cancer and Clinical Oncology;1986-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3